Clodronate decreases the frequency of skeletal metastases in women with breast cancer
- 1 December 1996
- Vol. 19 (6), 663-667
- https://doi.org/10.1016/s8756-3282(96)00285-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Use of Clodronate in Disorders of Calcium and Skeletal Metabolism1Published by S. Karger AG ,2015
- Cyclical intravenous clodronate in postmenopausal osteoporosis: Results of a long-term Clinical trialBone, 1996
- Etidronic AcidDrugs & Aging, 1994
- The assessment of vertebral deformity: A method for use in population studies and clinical trialsOsteoporosis International, 1993
- A double-blind, crossover trial of intravenous clodronate in metastatic bone painJournal of Pain and Symptom Management, 1992
- An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to boneBone, 1991
- BisphosphonatesDrugs, 1991
- Parathyroid Hormone-Like Proteins: Biochemical Responses and Receptor Interactions*Endocrine Reviews, 1989
- Measuring serum calcium.BMJ, 1985
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983